A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study

Identificadores
Identificadores
Fecha de publicación
2011Título de revista
Clinical & Translational Oncology
Tipo de contenido
Artigo
